And it's not a recent situation, it has been funded for years.Compared to previous months it seems to hold above .010 , as sell sentiment diminished influenced by the fact that whoever has followed this over the years doesn't really want to miss the human trial announcements:
"As previously announced to the market, Invion will be commencing Phase 1b human trials of
IVX-PDT to treat skin cancer, while Peter MacCallum Cancer Institute will be commencing
studies using IVX-PDT for the treatment of ano-genital cancer in 2020. "
They made progress in the past 2 years releasing positive progress with no failures every 3/6 months.So they make give us something late Q1/start Q2, or even before.
Once they begin the human trials there will be no turning back . But by all means, I really don't want to be to positive as I'm still accumulating.
DYOR Boys and girls!
- Forums
- ASX - By Stock
- Ann: Appendix 4C - December 2019 quarter
IVX
invion limited
Add to My Watchlist
0.00%
!
13.5¢

And it's not a recent situation, it has been funded for...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.43M |
Open | High | Low | Value | Volume |
12.5¢ | 13.5¢ | 12.5¢ | $3.286K | 26.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24920 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 9938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24920 | 0.125 |
3 | 209200 | 0.120 |
2 | 227489 | 0.115 |
2 | 15520 | 0.105 |
5 | 65300 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 9938 | 1 |
0.140 | 25770 | 2 |
0.145 | 92607 | 3 |
0.150 | 146065 | 4 |
0.155 | 110008 | 2 |
Last trade - 15.31pm 17/06/2025 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online